Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements (French, HTML)

View metadata and access the original French HTML file: Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements.

Format

HTML

Access

file-only

Publisher-reported update

2023-10-28

This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.

Access original file